Chlorophyll / Chlorophyllin

Chlorophyll a, Chlorophyll b, Sodium-Copper Chlorophyllin (CHL)
Evidence Level
Moderate
3 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Chlorophyll, often supplemented as water-soluble chlorophyllin, is the green pigment of plants, taken as a supplement or liquid drops for internal deodorizing of body and breath odor, antioxidant support, and as a popular wellness and skin trend. It also gives green superfood drinks their color. Liquid chlorophyll is commonly used at about 100 to 300 mg per day in water, with green vegetables as the natural dietary source. Chlorophyllin is generally very safe and well tolerated; it can harmlessly tint stool green and, at high doses, cause photosensitivity, so sun protection is wise. Its trendy skin-clearing claims are largely anecdotal.

Studied Dose AFLATOXIN PROTECTION: 100 mg sodium copper chlorophyllin 3×/day (300 mg/day total). DEODORIZER (FDA OTC): 100-200 mg/day (Derifil, Nullo). Take with meals.
Active Compound Chlorophyll a (the dominant plant chlorophyll), chlorophyll b. Pharmaceutical/supplement form: sodium copper chlorophyllin (CHL) — water-soluble salt with copper substituting for magnesium in the porphyrin ring

Benefits

Reduction of aflatoxin-DNA adducts (high-risk populations)

Egner 2001 (, PNAS) double-blind placebo-controlled RCT in Qidong, China — adults unavoidably exposed to dietary aflatoxin (high liver cancer region) received 100 mg CHL three times daily. Result: 55% reduction (median) in urinary aflatoxin-N7-guanine adduct excretion vs placebo. Adduct is biomarker of carcinogen-DNA damage associated with hepatocellular carcinoma risk. Excellent compliance, no toxicities. The strongest single piece of evidence for chlorophyllin chemoprevention.

Internal deodorizer (FDA-approved OTC)

Sodium copper chlorophyllin is FDA-approved as OTC drug (Derifil, Nullo) for fecal odor reduction in incontinence. Mechanism unclear but established practical effect. Modest evidence beyond product label claims; works for some users but not all. Has been used clinically since 1950s.

Mechanism: complexes with carcinogens in gut

Chlorophyllin forms tight molecular complexes (Kd ~1.4 μM) with aflatoxin B1 and other planar polycyclic carcinogens (heterocyclic amines from cooked meat, polycyclic aromatic hydrocarbons from grilled food/smoke). These complexes are too large to absorb across gut wall, effectively binding carcinogens in lumen and increasing fecal excretion. Validated in human pharmacokinetic studies.

Modest oral wound healing and skin support

Older evidence (1950s-60s) suggests chlorophyllin promotes wound healing, particularly for chronic ulcers and pressure sores. Recent reformulations of chlorophyllin in burn dressings and oral mucositis preparations show some clinical benefit. Generally a minor traditional use compared to dedicated wound care interventions.

Potential weight management role (very limited evidence)

RCT (Appetite, n=38 women) showed thylakoid (chlorophyll-rich plant membrane) supplementation reduced craving for sweet/savory foods and improved satiety. However, this is thylakoid (a complex chloroplast membrane), not pure chlorophyll. Single small trial. The broader 'chlorophyll for weight loss' claims popular on social media lack rigorous RCT support.

Mechanism of action

1

Carcinogen complex formation (the dominant chemoprevention mechanism)

Chlorophyllin's planar porphyrin ring forms π-π stacking complexes with planar polycyclic aromatic compounds — including aflatoxin B1, AFB1-8,9-epoxide (the ultimate carcinogenic metabolite), heterocyclic amines (PhIP, IQ from grilled meat), and PAHs (BaP from smoke/grilled food). Complex Kd ~1.4 μM. The complexes are non-absorbable, increasing fecal carcinogen excretion. This is the proven mechanism for the Qidong RCT reduction in AFB-N7-guanine.

2

Antioxidant activity (modest in vivo)

Chlorophyll and chlorophyllin scavenge various reactive oxygen species and reduce lipid peroxidation in vitro. The copper (in CHL) and magnesium (in native chlorophyll) centers can participate in redox chemistry. Clinical antioxidant relevance is modest — many other dietary antioxidants are more efficient.

3

Phase II detoxification enzyme induction

Chlorophyllin induces NAD(P)H:quinone oxidoreductase 1 (NQO1) and glutathione-S-transferase activity in vitro and in some animal studies. May contribute to chemoprevention beyond direct carcinogen complexation. Effect modest compared to dedicated Nrf2 activators (sulforaphane, curcumin).

4

Chlorin e4 ethyl ester metabolite

Egner 2000 (PMID 10995263) identified copper chlorin e4 ethyl ester in serum of Qidong CHL trial participants — confirming systemic absorption of a CHL-derived metabolite. Provides additional evidence that chlorophyllin is bioavailable beyond just luminal binding effects.

Clinical trials

1
Chlorophyllin in Aflatoxin-Exposed Population (Pivotal Clinical Trial)

Double-blind, placebo-controlled, randomized clinical trial (Egner PA, Wang JB, Zhu YR, Zhang BC, Wu Y, Zhang QN, Qian GS, Kuang SY, Gange SJ, Jacobson LP, Helzlsouer KJ, Bailey GS, Groopman JD, Kensler TW 2001, PNAS 98(25):14601-14606, doi:10.1073/pnas.251536898).

180 adults from Qidong, Jiangsu Province, China — a high-risk region for HBV-related hepatocellular carcinoma where dietary aflatoxin exposure is unavoidable. Randomized to 100 mg sodium copper chlorophyllin (CHL) three times daily or placebo for 12 weeks. Urinary aflatoxin-N7-guanine adducts measured.

Median 55% reduction in urinary excretion of aflatoxin-N7-guanine in CHL group vs placebo (p<0.05). The biomarker is derived from the ultimate carcinogenic metabolite of aflatoxin B1 and is associated with increased risk of hepatocellular carcinoma in prospective epidemiologic studies. Outstanding compliance; no toxicities observed. Concluded CHL is safe and effective agent for individuals unavoidably exposed to aflatoxin. Foundational chemoprevention clinical trial — among most rigorous evidence supporting any dietary supplement intervention.

2
Chemoprevention with Chlorophyllin Review

Comprehensive review (Egner PA, Muñoz A, Kensler TW 2003, Mutat Res 523-524:209-216, doi:10.1016/s0027-5107(02)00337-8).

Review of chlorophyllin chemoprevention literature including the Qidong human trial, animal models, and mechanistic studies.

Established CHL as safe and effective intervention for populations unavoidably exposed to aflatoxin. Mechanism centered on carcinogen molecular complex formation blocking bioavailability. Authors noted that combination with hepatitis B virus reduction efforts is critical for liver cancer prevention. The most authoritative review of chlorophyllin chemoprevention from the lead investigator team.

3
Chlorophyll vs Chlorophyllin Pharmacokinetics in Humans

Unblinded crossover pharmacokinetic study (Jubert C, Mata J, Bench G, Dashwood R, Pereira C, Tracewell W, Turteltaub K, Williams D, Cancer Prev Res 2(12):1015-1022, doi:10.1158/1940-6207.CAPR-09-0099).

4 healthy human volunteers receiving Institutional Review Board-approved dose of 14C-aflatoxin B1 (30 ng, 5 nCi) in capsule with or without natural chlorophyll (Chla) or chlorophyllin (CHL) cotreatment. Blood and cumulative urine over 72 hours. 14C-AFB1 measured by accelerator mass spectrometry.

Both Chla and CHL reduced AFB1 absorption and circulating levels — confirming bioavailability-blocking mechanism extends to NATURAL chlorophyll (from food sources) and not just water-soluble CHL salt. Results extended Qidong clinical trial findings to natural dietary chlorophyll. Important rationale for green leafy vegetable consumption in aflatoxin-exposed populations.

Side effects and drug interactions

Common Potential side effects

Generally extremely well-tolerated; FDA GRAS for chlorophyllin as food additive.
Green-stained tongue, teeth, urine, stool — harmless and reversible color change.
GI symptoms (mild): nausea, abdominal cramps, diarrhea at high doses.
Rare allergic skin reactions with topical use.
Photosensitivity: very rare; theoretical due to porphyrin photochemistry — generally not clinically relevant at typical doses.

Important Drug interactions

Methotrexate: chlorophyllin may reduce methotrexate clearance (animal data); monitor in oncology use.
Iron supplements: minor competitive absorption effects; clinical relevance limited.
Photosensitizing drugs: theoretical additive photosensitivity (very rare).
Anticoagulants: theoretical mild antiplatelet effect; clinically minor.
Generally compatible with most medications at typical supplement doses.

Frequently asked questions about Chlorophyll / Chlorophyllin

What is chlorophyll used for?

Chlorophyll (often as water-soluble chlorophyllin) is the green pigment of plants, taken as a supplement or liquid drops for internal deodorizing (body and breath odor), antioxidant support, and as a popular wellness and skin trend.

What is chlorophyll good for?

It is used as a natural internal deodorant (for body and breath odor), for antioxidant support, and is marketed for skin and detox, though much of the trendy skin-clearing evidence is anecdotal. It also gives green superfood drinks their color.

How much chlorophyll should I take?

Liquid chlorophyll is commonly used at about 100 to 300 mg per day (a teaspoon or so in water); follow product labeling. Green vegetables are the natural dietary source.

Is chlorophyll safe?

Chlorophyllin is generally very safe and well tolerated; it can harmlessly tint stool green and rarely cause mild digestive upset. It may cause photosensitivity at high doses, so use sun protection. It is a low-risk supplement.

What is Chlorophyll / Chlorophyllin?

Chlorophyll, often supplemented as water-soluble chlorophyllin, is the green pigment of plants, taken as a supplement or liquid drops for internal deodorizing of body and breath odor, antioxidant support, and as a popular wellness and skin trend. It also gives green superfood drinks their color.

What is Chlorophyll / Chlorophyllin used for?

Chlorophyll / Chlorophyllin is researched primarily for Detox & Cleanse, Antioxidant, and Liver Health. Egner 2001 (, PNAS) double-blind placebo-controlled RCT in Qidong, China — adults unavoidably exposed to dietary aflatoxin (high liver cancer region) received 100 mg CHL three times daily.

What is the recommended dosage of Chlorophyll / Chlorophyllin?

The clinically studied dose is Aflatoxin protection: 100 mg sodium copper chlorophyllin 3×/day (300 mg/day total). Deodorizer (FDA OTC): 100-200 mg/day (Derifil, Nullo). Take with meals. Always follow the product label and check with a healthcare provider for personal advice.

Is Chlorophyll / Chlorophyllin safe, and does it have side effects?

For most healthy adults, Chlorophyll / Chlorophyllin is well tolerated at studied doses. Reported effects can include: Generally extremely well-tolerated; FDA GRAS for chlorophyllin as food additive. Green-stained tongue, teeth, urine, stool — harmless and reversible color change. It may also interact with some medications. Chlorophyll / Chlorophyllin is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Chlorophyll / Chlorophyllin interact with any medications?

Possible interactions include: Methotrexate: chlorophyllin may reduce methotrexate clearance (animal data); monitor in oncology use. Iron supplements: minor competitive absorption effects; clinical relevance limited. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Chlorophyll / Chlorophyllin?

NutraSmarts rates the evidence for Chlorophyll / Chlorophyllin as Moderate (3 out of 5). It is backed by 3 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Egner PA, Wang JB, Zhu YR, Zhang BC, Wu Y, Zhang QN, Qian GS, Kuang SY, Gange SJ, Jacobson LP, Helzlsouer KJ, Bailey GS, Groopman JD, Kensler TW. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci U S A. 2001;98(25):14601-6. doi: 10.1073/pnas.251536898.PubMedUsed to support: Randomized controlled trial in which chlorophyllin reduced aflatoxin-DNA adducts in people at high risk of liver cancer. The landmark human study behind chlorophyll's detox and liver-protective framing (it binds dietary carcinogens).
  2. Egner PA, Muñoz A, Kensler TW. Chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin. Mutat Res. 2003;523-524:209-16. doi: 10.1016/s0027-5107(02)00337-8.PubMedUsed to support: Study of chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin, supporting its carcinogen-binding action. Reinforces the detox and liver use.
  3. Sudakin DL. Dietary aflatoxin exposure and chemoprevention of cancer: a clinical review. J Toxicol Clin Toxicol. 2003;41(2):195-204. doi: 10.1081/clt-120019137.PubMedUsed to support: Clinical review of dietary aflatoxin exposure and chemoprevention, including chlorophyllin's protective mechanism. Background for the detox framing.
  4. Kensler TW, Egner PA, Wang JB, Zhu YR, Zhang BC, Lu PX, Chen JG, Qian GS, Kuang SY, Jackson PE, Gange SJ, Jacobson LP, Muñoz A, Groopman JD. Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas. Gastroenterology. 2004;127(5 Suppl 1):S310-8. doi: 10.1053/j.gastro.2004.09.046.PubMedUsed to support: Review of liver-cancer chemoprevention in aflatoxin-endemic areas, in which chlorophyllin reduces carcinogen uptake. Supports the liver and detox uses.